Compare CVS Health Corp (CVS) vs J B Hunt Transport Services Inc (JBHT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs J B Hunt Transport Services Inc — how do they compare? CVS Health Corp trades at $86.25 (market cap $112.49B), while J B Hunt Transport Services Inc trades at $230 (market cap $20.91B). The key difference: CVS Health Corp is far larger — about 5.4× J B Hunt Transport Services Inc's market cap, and CVS Health Corp pays the higher dividend (3.02%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and J B Hunt Transport Services Inc for 45 Days on average.
| CVS | JBHT | |
|---|---|---|
Market Cap | $112.49B | $20.91B |
Volume | 8,467,392 | 684,242 |
Sector | Health | Industrials |
52-Week High | $110.60 | $298.41 |
52-Week Low | $70.08 | $137.09 |
Typical Hold Time | 83 Days | 45 Days |
Enterprise Value | $174.83B | $22.05B |
Dividend Yield | 3.02% | 0.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
JBHT trades at $228.42, up 1.1% with bearish technical signals but strong fundamentals. The company has beaten earnings estimates for three consecutive quarters with Q3 2026 results pending. Revenue stabilized at $12B in 2025 after previous declines, while profitability improved with 5.31% net margin. Analyst consensus remains strongly bullish with $287.53 price target despite ongoing securities investigations creating headline risk.
The stock presents a divergence between bearish technical indicators and positive fundamental trajectory. Upside potential exists from earnings momentum and industry tailwinds, but risks include legal investigations and cost pressures. Wall Street's 58.7% buy rating suggests confidence in long-term value despite near-term volatility from legal overhangs and fuel cost challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About J B Hunt Transport Services Inc
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →
